Abstract:Increasing evidence has shown that the transcription factor SOX4 is closely associated with the development and progression of many malignant tumors. However, the effect of SOX4 on breast cancer is unclear. In this study, we purposed to investigate the role of SOX4 in the growth and metastasis in breast cancer and the underlying mechanism. Moreover, the effect of SOX4 on cancer cell resistance to chemotherapeutic agents was also evaluated in vitro and in vivo. We used lentivirus technique to ectopically express SOX4 in MDA-MB-231 and SUM149 cells or knockdown SOX4 in BT474 cells, and examined the effect of these changes on various cellular functions. MTT assay was used to determine the cell viability as well as resistance to chemotherapeutic agents. The regulation of SOX4 on epithelial-mesenchymal transition (EMT)-related genes was analyzed using qRT-PCR. The binding of SOX4 to the CXCR7 gene was demonstrated using chromatin immunoprecipitation assay and dual-luciferase reporter activity assay. The effect of SOX4/CXCR7 axis on metastasis was examined using Transwell migration and Matrigel invasion assays. The expression of SOX4/CXCR7 in primary tumors and metastatic foci in lymph nodes was assessed using immunohistochemistry. Cellular morphology was investigated under phase contrast microscope and transmission electron microscopy. Moreover, the effect of SOX4 on tumor growth, metastasis, and resistance to chemotherapy was also studied in vivo by using bioluminescent imaging. SOX4 increased breast cancer cell viability, migration, and invasion in vitro and enhanced tumor growth and metastasis in vivo. It regulated EMT-related genes and bound to CXCR7 promoter to upregulate CXCR7 transcription. Both SOX4 and CXCR7 were highly expressed in human primary tumors and metastatic foci in lymph nodes. Treatment of breast cancer cells with the CXCR7 inhibitor CCX771 reversed the SOX4 effect on cell migration and invasion. Ectopic expression of SOX4 increased the susceptibility of cells to paclitaxel. SOX4 plays an important role in the growth and metastasis of breast cancer. SOX4/CXCR7 may serve as potential therapeutic targets for the treatment. Paclitaxel may be a good therapeutic option if the expression level of SOX4 is high.

Role of CXCR4 expression in progress and prognosis of breast cancer

Recombination of CXCR4, VEGF, and MMP-9 predicting lymph node metastasis in human breast cancer.

[Significance of Expression of Stromal Cell Derived Factor 1 and CXCR4 in Invasive Breast Cancer].

The role of CXC chemokine ligand 4/CXC chemokine receptor 3-B in breast cancer progression

Expression of CXCR4 and Breast Cancer Prognosis: a Systematic Review and Meta-Analysis

Expression and Clinical Significance of the CXC Chemokine Receptor-4 (CXCR4) in Breast Cancer

Aberrant expression of CXCR4 significantly contributes to metastasis and predicts poor clinical outcome in breast cancer.

Cytoplasmic CXCR4 High-Expression Exhibits Distinct Poor Clinicopathological Characteristics and Predicts Poor Prognosis in Triple-Negative Breast Cancer

The role of SDF-1 and its receptor CXCR4 in tumor metastasis]

The Impact of Chemokine Receptor CXCR4 on Breast Cancer Prognosis: A Meta-Analysis

Research progress on SDF-1/CXCR4 axis in tumor

SOX4 promotes the growth and metastasis of breast cancer

Expression of CXCR4 in Oral Squamous Cell Carcinoma: Correlations with Clinicopathology and Pivotal Role of Proliferation

Roles of CXCL12/CXCR4 axis in tumor growth and metastasis and related mechanisms

Study On Cxcr4/Sdf-1 Alpha Axis In Lymph Node Metastasis Of Cervical Squamous Cell Carcinoma

CXCL12/CXCR4 and breast cancer

Role of CXCR4 in Lymph Node Metastasis Promoted by VEGF-C in Gastric Carcinoma

CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression

Research progress of SDF-1/CXCR4 and biological behaviors of tumor

Expression of Cxcl14 and Its Anticancer Role in Breast Cancer

Correlation Effect of EGFR and CXCR4 and CCR7 Chemokine Receptors in Predicting Breast Cancer Metastasis and Prognosis